Bret M.

Bret M. possesses extensive experience in the biostatistics and clinical development fields, serving as Head of Biostatistics and Head of Early Clinical Development Statistics at Regeneron. Prior roles include Director of Quantitative Pharmacology and Pharmacometrics, Director of Modeling and Simulation, and Director of Clinical Biostatistics at Merck. Bret M. holds a Ph.D. in Statistics from the University of Minnesota (1992-1998) and a BS in Applied Mathematics/Operations Research from Carnegie Mellon University (1988-1991).